Regeneron Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue3.61B3.88B3.75B3.68B3.03B3.79B3.72B3.55B
Cost of Goods Sold669.4M584.6M521.6M530.2M464.3M565.4M491.1M480.2M
Gross Profit2.94B3.30B3.23B3.15B2.56B3.22B3.23B3.07B
R&D Expenses1.65B1.63B1.56B1.43B1.34B1.43B1.33B1.22B
Operating Expenses2.29B2.42B2.21B2.07B1.97B2.23B2.05B2.00B
Operating Income642.9M879.9M1.03B1.08B591.7M990.2M1.18B1.07B
Other Income / Gains188.3M163.8M736.5M439.2M313.3M-32.1M313.5M558.5M
Net Income727.2M844.6M1.46B1.39B808.7M917.7M1.34B1.43B
EPS (Diluted)6.998.2114.0913.247.588.5312.4013.25
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.8140.8490.8610.8560.8470.8510.8680.865
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses647.7M775.0M657.8M634.2M633.0M792.2M714.4M758.8M
Other Expenses018.7M-10.0M0015.5M8.0M14.6M
Cost And Expenses2.96B3.00B2.73B2.60B2.44B2.80B2.54B2.48B
Interest Income183.5M193.3M175.1M174.8M173.5M183.1M187.4M179.4M
Interest Expense12.9M12.2M19.3M3.6M8.7M10.5M13.8M14.8M
Depreciation And Amortization123.2M145.0M136.7M135.1M126.9M126.4M121.7M120.7M
Ebitda967.3M1.20B1.92B1.66B1.04B1.09B1.63B1.76B
Ebitdaratio0.2680.3090.5110.4510.3440.2890.4380.497
Operating Income Ratio0.1780.2270.2730.2940.1950.2610.3170.302
Income Before Tax831.2M1.04B1.76B1.52B905.0M958.1M1.49B1.63B
Income Before Tax Ratio0.2310.2690.470.4130.2990.2530.4010.459
Income Tax Expense104.0M199.1M303.3M127.1M96.3M40.4M152.4M195.8M
Net Income Ratio0.2020.2170.3890.3790.2670.2420.360.404
Epsdiluted6.757.8613.6212.817.278.0611.5412.41
Weighted Average Shs Out104.0M102.9M103.6M105.1M106.7M107.9M108.1M108.1M
Weighted Average Shs Out Dil107.7M107.5M107.2M108.6M111.2M113.8M116.2M115.4M